KRAS and lung cancer: Platonova et al. (147) found that NK cell infiltration is not correlated with clinical outcomes in NSCLC, similar to the finding by Platonova et al. (147), we recently observed that NK cell depletion in late-stage Kras-driven mouse lung cancer does not influence tumor development (35).